Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,377

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
NewbornExtreme PrematurityPretrm Infants
Interventions
OTHER

Premex Protocol

"This protocol presupposes stages during which staff are informed and trained. It is based on the following principles:~* Administration of corticosteroid therapy to all eligible women, independent of the decision about active or palliative care~* A prognostic evaluation in a non-emergency meeting of the obstetricians and neonatologists/pediatricians involved, no longer based only on gestational age, and enabling the team to provide consistent, consensual, and individualized information to parents;~* A joint decision about the obstetric and neonatal (active or palliative) care to be proposed to parents at the end of this evaluation;~* An interview with parents, also on non-emergency basis, to give them information about the child's prognosis and the management proposed, to answer their questions, and to obtain their opinion;~* Management at birth consistent with that decided in consultation with the parents."

Trial Locations (1)

75014

Hôpital Cochin, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER